Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Estramustine in Metastatic Breast Cancer
NCT00003066Phase 2Unknown
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Feb 1997
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and estramustine in breast cancer, sponsored by Herbert Irving Comprehensive Cancer Center. Primary endpoints: Objective Response Rate, Duration of Response and 2 more. Status: unknown.
02
Drugs
docetaxelestramustine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003066.